Today: 17 May 2026
Verizon stock today: VZ slips as fresh SEC filings hit tape; rates and earnings loom
2 January 2026
1 min read

Verizon stock today: VZ slips as fresh SEC filings hit tape; rates and earnings loom

NEW YORK, Jan 2, 2026, 2:26 PM ET — Regular session

Verizon Communications Inc shares edged lower on Friday after a cluster of U.S. regulatory filings detailed year-end “phantom stock” transactions by senior executives. The stock was down 0.1% at $40.67 as of 2:26 p.m. ET, after trading between $40.32 and $40.90.

The disclosures land as investors reset positions at the start of 2026, with interest-rate expectations back in focus. Verizon is widely held for its steady cash flows, making it one of the telecom names that can move with rates as investors compare dividend stocks with bond yields.

Treasury yields were higher on Friday, with the benchmark 10-year yield up about 2.4 basis points at 4.177%, according to a Reuters report. Rising yields can make income-oriented equities less attractive relative to bonds.

In separate Form 4 filings — the SEC’s disclosure for insider transactions — CEO Daniel H. Schulman and CFO Anthony T. Skiadas reported acquiring 228.902 and 149.514 phantom stock units, respectively, in transactions dated Dec. 31, 2025. Director Hans Erik Vestberg and executive vice president Joseph J. Russo also reported phantom stock acquisitions on the same date, filings showed.

Phantom stock is a bookkeeping unit linked to the value of a company’s shares. The filings said Verizon’s phantom stock is cash-settled under its deferred compensation plan, which lets executives defer pay and receive it later under pre-set conditions.

Insider activity can draw attention because executives may have deeper insight into business trends than outside investors. But transactions tied to compensation or deferral plans do not necessarily signal open-market buying.

Verizon traded in line with telecom peers on Friday. AT&T fell 0.7% and T-Mobile slid about 1.3% in afternoon trading.

“The market is looking for direction,” Matthew Maley, chief market strategist at Miller Tabak, said in a Reuters report. Investors are watching the U.S. jobs report due Jan. 9 and the consumer price index due Jan. 13, while Fed funds futures imply little chance of a rate cut at the late-January meeting and close to a 50% chance of a quarter-point cut in March, the report said. Reuters

For Verizon, that macro calendar matters because rate swings can shift demand for high-dividend, defensive shares. A softer data run that pushes yields lower typically supports those stocks, while hotter inflation or firmer payrolls can do the opposite.

Investors also have Verizon’s next results in view. The company has said it will report fourth-quarter 2025 earnings on Jan. 30 at 8:30 a.m. ET.

In that report, traders will focus on wireless subscriber trends, the level of promotional spending, and updates on free cash flow and capital spending — key measures for a company that markets itself as a steady cash generator.

With shares only modestly lower into mid-afternoon, Verizon’s near-term direction is likely to stay tethered to rate expectations and positioning ahead of the Jan. 30 earnings release.

Stock Market Today

  • Gemini Shares Jump Over 20% Following Founders' $100 Million Investment
    May 16, 2026, 6:18 PM EDT. Gemini Space Station shares soared more than 20% in premarket trading after the cryptocurrency exchange revealed a smaller quarterly loss than analysts anticipated. The surge came as founders Cameron and Tyler Winklevoss injected $100 million into the business, providing a significant capital lifeline amid challenging market conditions for crypto firms. This move aims to strengthen Gemini's financial position and support its ongoing operations.

Latest articles

Zeta Global Stock Gets a Snowflake Boost Before a Big Investor Test

Zeta Global Stock Gets a Snowflake Boost Before a Big Investor Test

17 May 2026
Zeta Global shares closed at $17.19, up 3.68% Friday, outperforming major indexes after joining Snowflake’s Open Semantic Interchange data initiative. The stock retreated to $17.14 after hours. Zeta will present at the JPM 2026 Global Technology, Media and Communications Conference on Monday. First-quarter revenue jumped 50% to $396 million, prompting a full-year guidance raise.
Johnson & Johnson Stock Fell Friday — The Week-Ahead Setup Investors Should Watch

Johnson & Johnson Stock Fell Friday — The Week-Ahead Setup Investors Should Watch

16 May 2026
Johnson & Johnson shares fell 1.77% to $226.71 Friday amid a broad market selloff but ended the week up about 2.4%. The NYSE is closed for the weekend, with trading set to resume Monday. Investors are watching upcoming neuropsychiatry data presentations and the global launch of the Shockwave C2 Aero Coronary IVL Catheter. No new earnings report is expected next week.
Vertiv Heads Into Friday After Turbulent Run This Week

Vertiv Heads Into Friday After Turbulent Run This Week

16 May 2026
Vertiv closed at $370.94 Friday, down 1.4% but up 9.1% for the week. The company urged shareholders to reject Tutanota’s mini-tender offer for up to 500,000 shares at $410, citing conditions tied to the stock price. RBC and Loop Capital issued bullish notes ahead of Vertiv’s May 19-20 investor conference. Shares traded at $368.61 after hours.
Investors Eye May 16 After Turbulent Week for Planet Labs

Investors Eye May 16 After Turbulent Week for Planet Labs

16 May 2026
Planet Labs shares fell 3.3% Friday to $41.62 but ended the week up 6.6%, boosted by new satellite launches and a European contract. The company released first images from three Pelican satellites, including Sweden’s first sovereign satellite, after a May 3 SpaceX launch. Planet now has nine AI-enabled Pelican satellites in orbit and plans more launches in 2026. Fourth-quarter revenue rose 41% to $86.8 million.
Hubble spots odd triple jets on interstellar comet 3I/ATLAS as radio search finds no alien signal
Previous Story

Hubble spots odd triple jets on interstellar comet 3I/ATLAS as radio search finds no alien signal

Kymera Therapeutics stock slides nearly 7% after CEO share-sale filing — what KYMR investors watch next
Next Story

Kymera Therapeutics stock slides nearly 7% after CEO share-sale filing — what KYMR investors watch next

Go toTop